Shares of Sibanye-Stillwater surged 6.3% to $11.22 after South Africa's minerals minister granted its subsidiary the right to transfer a critical mining license — the first concrete sign that a long-stalled uranium-and-gold deal is actually moving through Pretoria's bureaucracy. The jump adds roughly $1.2 billion in market value to a company still nursing a trailing twelve-month net loss, raising the question of how much future production the stock can safely price in today.
• The Government Said Yes — But Only to Step One of Three. This Section 11 consent represents the first of three sequential regulatory steps required to complete the transfer.
The next step is the Section 102 approval, which will separate the New Beisa Node from Sibanye's wider Beatrix mining operation; that application is currently being processed.
Regulatory deadlines run to December 6, 2026, for Sibanye's approvals and June 6, 2027, for the buyer's subsequent consent. Investors are celebrating a milestone, but the finish line is nearly a year away.
• The Buyer, Not Sibanye, Will Spend the Money. Sibanye is selling the Beatrix 4 shaft to Neo Energy Metals, which plans to develop New Beisa. This transaction allows for development without straining Sibanye's balance sheet.
Sibanye will become Neo Energy's largest shareholder with up to roughly 40% ownership and two board seats. In plain terms: Sibanye offloads capital risk while keeping upside through its equity stake — a low-cost bet on uranium's recovery.
• Uranium's Backdrop Makes the Bet Credible. Global uranium prices sat at $86.50/lb as of early August 2026 , well above the levels that mothballed Beatrix 4 in 2023. The global market for reliable primary supply is tightening, with sanctions and the Russia-Ukraine war constraining the nuclear fuel cycle.
Neo Energy targets annual production of 1–3 million pounds of uranium and up to 100,000 ounces of gold over a 20-year mine life.
• The Stock's Fundamentals Still Flash Caution. Over the past 12 months, Sibanye posted $7.83 billion in revenue but a net loss of $312 million.
Free cash flow was a threadbare $85 million.
Q1 2026 adjusted EBITDA surged 371% year-on-year to $1.04 billion , driven by PGM prices — not uranium. Today's rally prices in regulatory progress on an asset Sibanye won't even operate directly. Analysts' average price target is $17.02, implying 73% further upside, with a consensus "Buy" rating — but that target rests on commodity prices staying elevated across gold, PGMs, and uranium simultaneously.